Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) shares were down 19% on Tuesday . The stock traded as low as $1.62 and last traded at $1.62. Approximately 300 shares were traded during trading, a decline of 100% from the average daily volume of 75,729 shares. The stock had previously closed at $2.00.
Mesoblast Trading Down 19.0 %
The stock has a fifty day simple moving average of $1.80 and a two-hundred day simple moving average of $1.17.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
See Also
- Five stocks we like better than Mesoblast
- What is a Bond Market Holiday? How to Invest and Trade
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Technology Stocks Explained: Here’s What to Know About Tech
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
